Carisma Therapeutics nabs $59m Series B
Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding.
Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination
